ACIU · CIK 0001651625
AC IMMUNE SA
Annual figures as reported, FY2014–FY2025. Ratios and growth rates derived on-page.
Pharmaceutical Preparations
Company profile
Revenue
CHF 3.6M
▼ −86.9% vs FY2024
Net income
−CHF 70.4M
▼ −38.4% vs FY2024
Free cash flow
−CHF 70.2M
▼ −207.5% vs FY2024
Diluted EPS
−CHF 0.70
▼ −37.3% vs FY2024
Revenue
Annual, as reported
Net income
Losses shown in terracotta
Recent quarters
momentum · last 12 quartersRevenue — Dec ’18 quarter
CHF 1.4M
▼ −91.5% vs Dec ’17
Net income — Dec ’18 quarter
−CHF 14.7M
▼ −452.5% vs Dec ’17
Revenue — trailing 12 months
CHF 7.2M
▼ −64.5% vs Dec ’17
Diluted EPS — trailing 12 months
−CHF 0.47
Quarterly revenue
Discrete quarters; Q4 derived from the annual figure
Quarterly net income
Losses shown in terracotta
| Quarter | Revenue | Rev. YoY | Gross margin | Net income | Net margin | Diluted EPS |
|---|---|---|---|---|---|---|
| Dec ’18 | CHF 1.4M | −91.5% | — | −CHF 14.7M | −1046.2% | — |
| Sep ’18 | CHF 2.3M | 114.6% | — | −CHF 13.5M | −586.4% | — |
| Jun ’18 | CHF 2.0M | 169.3% | — | −CHF 11.1M | −549.5% | — |
| Mar ’18 | CHF 1.5M | −27.3% | — | −CHF 11.6M | −796.6% | — |
| Dec ’17 | CHF 16.4M | — | — | CHF 4.2M | 25.4% | CHF 0.07 |
| Sep ’17 | CHF 1.1M | — | — | −CHF 8.8M | −818.7% | −CHF 0.15 |
| Jun ’17 | CHF 753K | — | — | −CHF 12.3M | −1637.1% | −CHF 0.22 |
| Mar ’17 | CHF 2.0M | — | — | −CHF 9.5M | −471.3% | −CHF 0.17 |
Profitability & returns
quality of earningsMargins
Share of revenue kept at each line
Operating marginNet margin
Returns on capital
Net income vs year-end equity and assets
Return on equityReturn on assets
Cash flow
cash generationFree cash flow
Operating cash flow less capital expenditure
Operating cash flow
Net cash from operations
Shareholder returns
capital allocationDiluted shares outstanding
Falling count means buybacks outpace dilution
Balance sheet
financial positionStockholders’ equity
At fiscal year end
Growth rates
compounding, annualizedRevenue CAGR
−3.2%
3y
−25.4%
5y
−21.3%
10y
Share count change (split-adjusted)
+40.1%
5y
+118.8%
10y
Key ratios
derived per fiscal year| Fiscal year | Op. margin | Net margin | FCF margin | ROE | ROA | Current ratio |
|---|---|---|---|---|---|---|
| FY2025 | −1940.1% | −1971.6% | −1963.7% | −157.0% | −45.7% | 1.02× |
| FY2024 | −191.8% | −186.4% | 239.0% | −45.4% | −22.0% | 1.71× |
| FY2023 | −362.3% | −366.4% | −413.5% | −33.8% | −29.7% | 9.22× |
| FY2022 | −1800.4% | −1798.0% | −1901.1% | −41.9% | −38.1% | 11.16× |
| FY2021 | — | — | — | −31.5% | −27.9% | 10.12× |
| FY2020 | −397.0% | −401.3% | −396.8% | −28.7% | −25.9% | 16.53× |
| FY2019 | 40.3% | 41.1% | 48.3% | 16.7% | 15.2% | 16.72× |
| FY2018 | −716.9% | −737.1% | −664.6% | −28.7% | −25.9% | 14.75× |
| FY2017 | −111.3% | −130.4% | −118.0% | −22.6% | −20.0% | 13.28× |
| FY2016 | −45.0% | −30.6% | −28.2% | −5.0% | −4.5% | 15.61× |
| FY2015 | 47.6% | 51.9% | 112.2% | 28.5% | — | — |
| FY2014 | — | — | — | — | — | — |
Annual figures
as reported| Fiscal year | Revenue | Gross profit | Op. income | Net income | Diluted EPS | Op. cash flow | Capex | Total assets | Liabilities | Equity | Cash | LT debt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 | CHF 3.6M | — | −CHF 69.3M | −CHF 70.4M | −CHF 0.70 | −CHF 69.3M | CHF 900K | CHF 154.3M | CHF 109.4M | CHF 44.9M | CHF 26.8M | — |
| FY2024 | CHF 27.3M | — | −CHF 52.4M | −CHF 50.9M | −CHF 0.51 | CHF 65.8M | CHF 576K | CHF 230.9M | CHF 118.6M | CHF 112.3M | CHF 36.3M | — |
| FY2023 | CHF 14.8M | — | −CHF 53.6M | −CHF 54.2M | −CHF 0.64 | −CHF 60.4M | CHF 801K | CHF 182.8M | CHF 22.2M | CHF 160.6M | CHF 78.5M | — |
| FY2022 | CHF 3.9M | — | −CHF 70.8M | −CHF 70.8M | −CHF 0.85 | −CHF 73.6M | CHF 1.2M | CHF 185.9M | CHF 16.9M | CHF 169.0M | CHF 31.6M | — |
| FY2021 | CHF 0 | — | −CHF 79.0M | −CHF 73.0M | −CHF 0.97 | −CHF 65.7M | CHF 2.6M | CHF 261.4M | CHF 29.5M | CHF 232.0M | CHF 82.2M | — |
| FY2020 | CHF 15.4M | — | −CHF 61.3M | −CHF 61.9M | −CHF 0.86 | −CHF 59.5M | CHF 1.7M | CHF 238.7M | CHF 23.3M | CHF 215.5M | CHF 160.9M | — |
| FY2019 | CHF 110.5M | — | CHF 44.5M | CHF 45.4M | CHF 0.64 | CHF 55.2M | CHF 1.9M | CHF 299.3M | CHF 26.8M | CHF 272.4M | CHF 193.6M | — |
| FY2018 | CHF 6.9M | — | −CHF 49.5M | −CHF 51.0M | −CHF 0.82 | −CHF 44.1M | CHF 1.9M | CHF 196.6M | CHF 18.9M | CHF 177.6M | CHF 156.5M | — |
| FY2017 | CHF 20.3M | — | −CHF 22.5M | −CHF 26.4M | −CHF 0.46 | −CHF 22.1M | CHF 1.8M | CHF 132.0M | CHF 15.2M | CHF 116.8M | CHF 124.4M | — |
| FY2016 | CHF 23.2M | — | −CHF 10.5M | −CHF 7.1M | −CHF 0.14 | −CHF 5.6M | CHF 899K | CHF 156.1M | CHF 13.7M | CHF 142.4M | CHF 152.2M | — |
| FY2015 | CHF 39.1M | — | CHF 18.6M | CHF 20.3M | CHF 0.44 | CHF 44.1M | CHF 244K | — | — | CHF 71.0M | CHF 76.5M | — |
| FY2014 | — | — | — | — | — | — | — | — | — | CHF 23.5M | CHF 3.3M | — |
Latest filings
the most recent regulatory filings6-KForeign issuer report2026-06-30 ↗4PRIMARY DOCUMENT2026-06-15 ↗4PRIMARY DOCUMENT2026-06-15 ↗4PRIMARY DOCUMENT2026-06-15 ↗4PRIMARY DOCUMENT2026-06-15 ↗4PRIMARY DOCUMENT2026-06-15 ↗6-KForeign issuer report2026-06-11 ↗6-KForeign issuer report2026-06-11 ↗4PRIMARY DOCUMENT2026-05-18 ↗144Notice of proposed insider sale2026-05-15 ↗
Company logos by Elbstream and unavatar.
All third-party trademarks, service marks, logos, and brand names used on this site are the property of their respective owners. The use of these logos is for identification and illustrative purposes only and does not imply any affiliation, sponsorship, or endorsement by the respective owners.